Français

For Universal Life Investment Accounts

CI Global Health Sciences Corporate Class A

Sector Equity

As Of: Aug 31, 2022

Fund Objective

This fund’s objective is to obtain maximum long-term capital growth. It invests primarily in equity and equity-related securities of companies around the world that specialize in the health care or medical industry. This includes companies that provide goods and services to these companies and companies that the portfolio adviser believes would benefit from developments in the health sciences industry.

Asset Allocation

Asset Percent
US Equity 72.42%
International Equity 25.32%
Cash and Equivalents 2.26%

Sector Allocation

Sector Percent
Healthcare 92.31%
Exchange Traded Fund 3.49%
Cash and Cash Equivalent 2.26%
Consumer Services 1.94%

Geo Allocation

Region Percent
North America 74.68%
Europe 22.97%
Asia 2.35%

Top Holdings

Name Percent
UnitedHealth Group Inc 9.15%
Johnson & Johnson 7.28%
Novo Nordisk A/S Cl B 5.55%
Eli Lilly and Co 5.05%
AstraZeneca PLC 4.89%
Roche Holding AG - Partcptn 4.75%
Thermo Fisher Scientific Inc 3.96%
Merck & Co Inc 3.91%
Pfizer Inc 3.73%
Humana Inc 3.55%

Category

Sector Equity

General Info

Inception Date Jul 23, 1996
MER 2.34%
Total Assets
(in millions)
$152.07

UL Fees

Wave 33 or later
Life Dimensions (Low Fees) 1.00%
Life Dimensions 2.25%
Wealth Dimensions 1.00%
Wave 32 or earlier (2016 or earlier)
Life Dimensions 2.75%
Life Dimensions (Low Fees) 1.50%
UL Investment Loan Plan 2.75%
Ultimate Dimension 1.25%

Fund Management Company

CI Global Asset Management

Investment Style

This investment's style box characteristics are Large Growth.

Fund Growth

Period

Growth Summary

Table below lists the current growth and return for an investment of $10,000 at the fund's inception:

Investment Value $67,983.20
Rate of Return +579.83%
Values over period specified.

Legend

CI Global Health Sciences Corporate Class A

S&P/TSX Composite Index TR


Performance

1 Mth 3 Mth 6 Mth YTD 1 Yr 3 Yr 5 Yr 10 Yr Inception
Fund -4.0 -1.8 -7.2 -9.9 -15.9 5.8 2.4 8.9 7.6
S&P/TSX Composite Index TR -1.6 -6.0 -7.1 -7.2 -3.4 8.7 8.1 8.1 -
Quartile 4 3 2 1 2 3 4 4 -

Calendar Performance

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Fund -0.1 11.2 12.0 1.1 6.4 -19.1 14.1 19.6 61.8 30.4
S&P/TSX Composite Index TR 25.1 5.6 22.9 -8.9 9.1 21.1 -8.3 10.6 13.0 7.2
Quartile 4 3 4 3 4 4 3 3 1 1

Volatility

Volatility: 7

Risk vs. Return

Period

CI Global Health Sciences Corporate Class A

Median

Other - Sector Equity

Risk & Tax Efficiency

3 Yr 5 Yr 10 Yr
Standard Deviation 16.25 15.31 16.63
Beta 0.60 0.66 0.65
Alpha 0.01 -0.02 0.04
R-Squared 0.41 0.41 0.21
Sharpe Ratio 0.38 0.17 0.55
Sortino Ratio 0.43 0.05 0.64
Treynor 0.10 0.04 0.14
Tax Efficiency 81.98 60.40 86.55

Category

Sector Equity

General Info

Inception Date Jul 23, 1996
MER 2.34%
Total Assets
(in millions)
$152.07

UL Fees

Wave 33 or later
Life Dimensions (Low Fees) 1.00%
Life Dimensions 2.25%
Wealth Dimensions 1.00%
Wave 32 or earlier (2016 or earlier)
Life Dimensions 2.75%
Life Dimensions (Low Fees) 1.50%
UL Investment Loan Plan 2.75%
Ultimate Dimension 1.25%

Fund Management Company

CI Global Asset Management

Investment Style

This investment's style box characteristics are Large Growth.